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Abstract 
 
Hyperbranched polyglycerols (hbPGs) are one of the most popular hyperbranched polymers. 
Similar to its polyether analogue, poly(ethylene glycol) (PEG), hbPG exhibits excellent 
biocompatibility and immunogenicity. Moreover, owing to their facile synthetic nature and 
access to various architectures as well as the various functional groups, hbPGs have attracted 
significant attention as promising candidates for biomedical applications as well as polymer 
elctrolyte for battery application and polymeric support for catalysts. For these purpose, various 
kind of synthetic strategies and a huge number of PG derivatives are developed. 
In this thesis/dissertation, we cover the subject of “design and synthesis of stimuli-responsive 
hbPG”. First of all, the overview of the state of the art in hbPG research is given in part 1. After 
that, research results about “redox-degradable hbPG” and “light-responsive micelles of 
spiropyran initiated hbPG” in part 2 and 3, respectively. 
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Part 1. Introduction of Hyperbranched Polyglycerol and Its Derivatives 
 
1. Hyperbranched polymer 
Hyperbranched polymers (HBP) belong to a type of tree-like synthetic macromolecules which is called 
dendritic polymers.1 They are polymers which have densely branched structure and a many number of 
terminal group. Dendritic polymers are divided into dendrimers with completely branched topologies 
and HBP with imperfectly branched or irregular structure. A schematic illustration of dendrimers and 
HBP is shown in Figure 1a. For a given number of monomer and generation, dendrimer has only one 
structure but HBP can have a large number of structure because of the different ways of distribution of 
branched and linear monomers. 
In experiments, while dendrimers are obtained in multi-step “organic” synthetic method, HBP are 
synthesized in a single polymerization step, using AB2 (ABm) type multifunctional monomers.2 
Therefore, HBP usually have randomly branched structure and highly dispersed system with different 
molecular sizes (often exceeding Mw / Mn = 5) and topologies. Furthermore, HBP have characteristics 
of randomly distributed functional groups on their dendritic structure.3 However, this allow the change 
of their properties by simply modifying end-group modification, which should be powerful tool for 
polymer design for a various kind of promising applications.4 HBP also show the absence of 
entanglements, which lead to low viscosities in comparison with the linear or star branched polymers. 
Unlike dendrimers which are obtained by multistep process,5 HBP can be facilely and cost-effectively 
obtained with one-step process. This characteristic is important advantage for their application in 
industry.  
With significant academic and industrial interest, it is critical issue to develop the well-defined HBP 
and their parameter and control the molecular weight, polymer distribution (PDI) and degree of 
branching (DB). Dendrimers contain only dendritic and terminal units and thus don’t possess any linear 
units. In case of perfectly branched structure, the DB is 1, while DB of linear polymers is 0. Accordingly 
DB of HBP is between 0 and 1 (Figure 1b).6  
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Figure 1. (a) Schematic illustration of dendrimer with generation 3 and HBP. (b) Comparison of linear, 
HBP and dendrimers as a function of the degree of branching (D: dendritic unit, L: linear unit, T: 
terminal unit). 
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In this sense, a theory on the degree of branching was studied and established in 1997 by Frey et al.7, 
8 This formula is defined for ABm (m≥2) type monomers. 
 
In this equation, the DB is determined by using NMR spectroscopy based on model polymers, which 
consist of all of units which are the linear, dendritic and terminal units. The DB is calculated by 
comparing the intensity of the NMR signals. 
The slow monomer addition (SMA) method is proper for ABm monomers, which results in control 
of the molecular weight and lower polydispersity (PDI). The first use of SMA method was reported by 
Moore et al. The experiments show that narrow polydispersity from 1.2 to 1.8 were obtained with 
various monomer/initiator ratio. 
As shown above, it is possible to synthesize the well-defined HBP with SMA of ABm monomer. 
One major problem of condensation polymerization is the production of low molecular weight 
byproduct which is produced during the polymerization. However, when the cyclic type monomers are 
used, we can avoid this difficulty and the polymerization can rapidly proceed to high molecular weight 
polymers. This technique employs a “latent AB2 monomer” where the B groups participate in the 
polymerization only after the A group is reacted. The driving force of this reaction is the ring opening. 
Glycidol which is the type of the oxiranes is considered as a monomer having structure of latent 
AB2-monomer. Based on the SMA method, Frey et al. succeed polymerization of the glycidol via 
anionic ring-opening multibranching polymerization (ROMBP) in 1999.9-11 The glycidol monomer is 
dropwise added to potassium or cesium alkoxide monomer for polymerization. Due to the extremely 
fast proton exchange in the period of polymerization, polymerization is proceeded to different 2 
direction (secondary and primary alcohols), which result in hyperbranched structure as shown in Figure 
2. The synthesized polymers are highly viscous liquid with transparence. 
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Figure 2. Mechanism of the base-catalyzed ROMBP of glycidol and structure of the resulting hbPG, 
which illustrate small fragment of the large polymer.  
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2. Hyperbranched polyglycerols and linear polyglycerols 
Poly(ethylene glycol) (PEG) and its derivatives are employed in a various areas, covering cosmetics, 
paper coating, detergents, polyurethanes, construction chemistry, textile modification, and for an 
tremendous variety of pharmaceutical applications.12, 13 The reason why PEG is widely used in so many 
fields is due to the unique properties of PEG.14, 15 In comparison with other synthetic polymers, PEG 
have excellent solubility in water and a various organic solvents. PEG shows no toxicity and 
immunogenicity and possess antifouling properties, which mean that PEG is highly biocompatible. 
Therefore, PEG is approved by the US-American Food and Drug Administration (FDA) for use in the 
human body. Conjugation of PEG to a drug or protein, which is called PEGylation,13, 16, 17  imparts a 
“stealth effect” and result in the increased hydrodynamic radius of the materials, which results in 
improved pharmacokinetics. 
However, there are some limits and disadvantages of PEG to be mentioned: (i) due to its linear 
structure, PEG have only two functional group, which limits further modification for the decoration of 
drug, targeting or imaging agents; (ii) oligo(ethylene glycol)s under a molecular weight of 400 g/mol-1 
show toxicity due to enzyme-catalyzed oxidation processes; (iii) It is controversially discussed that 
hypersensitivity reaction of PEG conjugated drugs are possible and (iv) it is reported that there are the 
complement activation by different molecular weight PEGs and rapid clearance of PEGylated 
liposomes from the blood stream.18 
Recently, polyglycerols (PG, also known as “polyglycidols”) are emerged as alternative to 
conventional PEG due to its structural similarity and multihydroxy-functionality (Figure 3a). It is 
interesting characteristics that various kind of PG architectures such as linear, hyperbranched or more 
complex structure can be easily obtained by different monomer and approach. With glycidol which is a 
latent AB2 monomer, hyperbranched polyglycerols (hbPGs) can be synthesized by anionic ROMBP. 
The synthesis and properties of kind of hbPG have been intensely researched.4, 8, 19, 20 The reaction of 
glycidol to branching direction can be inhibited by protecting the hydroxyl group. With this strategy, it 
is possible to synthesize and define various PGs with different architectures ranging from linear to 
hyperbranched structure or more complex architectures (Figure 3b). 
In contrast, the use of protected glycidol monomers such as ethoxyethyl glycidyl ether (EEGE) result 
in the linear polyglycerol (linPG) which shows a similar or higher biocompatibility profile.21 linPGs 
show no significant effects on cell viability, coagulation phenomenon, complement activation to date. 
In fact, ester of oligoglycerols which have up to 10 of degree of polymerization and quite broad 
polydispersity were approved by the FDA as food and pharmaceutical additives and have been widely 
applied in these field for several decades.22 
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Figure 3. (a) Chemical structure of PEG, linPG and hbPG. (b) Pathway to various architecture 
available based on PG. 
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3. Polyglycerol with complex polymer architectures and heterofunctionalies 
With the synthesis of well-defined lin or hbPG, various initiator, latent AB2 monomers and synthetic 
strategy have been introduced, giving heterofunctionality and complex polymer architectures.4, 8, 23 The 
overview given in Figure 4 propose the versatile synthetic strategy of glycidol and other functional 
epoxide comonomers. The first module I shows the various choice of functional initiator molecules. 
The second module II demonstrate that enormous kind of epoxide monomers can be easily 
copolymerized with each other either in a block or random manner. The third module which is terminal 
functionalization of the polyether polyol or PG result in new functions and properties. These three 
modules will be covered below. 
 
3.1. Variation of functional initiator 
The development of synthetic strategies that allow the introduction of functional core units with 
functionality and specific properties into PG structure is important approach because it is anticipated to 
add the characteristics of PG such as solubility and multifunctionalities to initiator core (Figure 4). The 
core initiator should have hydroxyl group for initiation reaction and suitable initiators are limited owing 
to rigorous oxyanionic polymerization condition. 
The incorporation of single amino group into polymer has attracted increasing interest because 
amino functionalities are useful functional group for the conjugation chemistry or attachment of 
biomolecules.24-26 In recent years, there are some development to introduce single amino group into the 
core of PG. Most of them use the protected amine-containing initiators to grow the PG. Protective 
groups which can be deprotected by catalytic hydrogenation are usually employed. Work on focal amine 
group containing PGs with different structure which were synthesized by anionic ring-opening 
polymerization (ROP) of EEGE was reported by Klok et al. Amino functional PGs were obtained with 
usage of a methoxybenzyl-protected aminoethanol or serinol initiator. After deprotection of the 
protective groups, the focal amino functional PGs were employed to prolong the circulation time of 
proteins. PG is a promising candidate for therapeutic proteins and can allow the combination of the 
“stealth effect” of polyether and multifunctional groups to conjugate the other biomolecules. 
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Figure 4. Overview of versatile synthetic strategy of PG or polyether polyol and its derivatives.  
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Recently, Frey group developed an initiator based on catechol which can induce universal adhesion 
(Figure 5a).27, 28 This initiator can allow the synthesis of various kind of catechol-functional PG. It is 
demonstrated that catechol moiety of catechol initiated hbPGs selectively bind to manganese oxide 
(MnO) nanoparticles. With this polymer, MnO nanoparticles are efficiently dispersed in aqueous 
solution, making them proper materials as contrast agents for magnetic resonance imaging. Cell 
viability test showed that all PG-coated MnO nanoparticles are highly biocompatible up to a 
concentration of 50 μg/mL. This concept can be used for a many kind of nanoparticles to give water 
solubility and antifouling properties. 
As an essential component of the lipid bilayer in cell membranes, cholesterol is an important 
molecule to synthesize amphiphilic architectures. Because presence of hydroxyl group in cholesterol, 
cholesterol can be readily used for anionic ROP without further modification. Frey et al. studied on 
cholesterol initiated PGs which are synthesized by ROP method with the cholesterol as an initiator 
(Figure 5b).29, 30 A series of cholesterol-initiated PGs have been prepared by employing glycidol and 
EEGE. 
Functional initiator that can undergo host-guest interaction to assemble supramolecular, complex 
polymer structures attracts the increasing interest. In recent, Frey et al. has developed adamantly 
methanol-initiated PGs (Figure 5c).31 These PGs are amphiphilic due to the hydrophobic adamantly 
residue, thus can form a complex with the hydrophobic cyclodextrin, which result in complex of 
supramolecular graft copolymer structure. This complex is consist of poly(methacrylate) backbone with 
cyclodextrin-functional and supramolecularly attached PG side chains. 
Recently, our group design the photo-responsive micelles using spiropyran initiated PG and 
investigated their potential for smart drug delivery (Figure 5d).32 Spiropyran is well-known 
photochromic molecule, which undergo a reversible transformation from colorless to pink-colored 
merocyanine after UV irradiation with significant polarity change from hydrophobic to hydrophilic. 
Thus, this polymer can be assembled to micelle in aqueous solution, but formed micelle can be 
disassembled upon UV-irradiation. With this properties, we studied on possibility as smart drug 
delivery carrier by observing the encapsulation and light-controlled release of model therapeutics (for 
detail information, see the part 3). 
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Figure 5. PGs with a (a) catechol, (b) cholesterol, (c) adamantly and (d) spiropyran as single focal 
group for metal oxide nanoparticle coating, multifunctional liposomes, supramolecular linear-g-
hyperbranched graft polymers and light-responsive micelles, respectively. 
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3.2. Random copolymers with functional epoxide monomer  
The polymerization of epoxide monomer via anionic ROP is established method to synthesize 
polyethers with different properties.33 It should be emphasized that the functionality of PG can be varied 
and increased by using the different functional epoxide monomers.34-36 
The synthesis of functional epoxide monomers containing functional group facilitate the 
incorporation of versatile functionalities such as hydroxyl groups, vicinal diol, amine, double bonds and 
triple bonds.23, 37-40 Usually, epichlorohydrin or glycidol are reacted with alcohol or amine bearing 
compounds for synthesis of functional epoxide monomers. The monomers are typically prepared by 
nucleophilic attack of the alcohol or amine on the methylene group of the epichlorohydrin-ring, 
followed by ring-closure via intramolecular nucleophilic substitution (SNi). In cases of dibenzyl amino 
glycidol (DBAG), the intermediate chlorohydrin can be isolated. Another strategy uses the alcohol of 
glycidol, which make EEGE, the protected glycidol monomer by ethyl acetal protective group by 
protecting hydroxyl group with ethyl vinyl ether under acidic catlysis. An overview of reaction 
mechanism is shown in Figure 6a. Well defined materials, which have good solubility and 
biocompatibility can be obtained with the combination of (i) and (ii) and this polymer is promising 
candidate for various applications. Figure 6b shows an overview of the various kind of functional 
epoxide. 
By using mixtures of glycidol with various functional epoxide monomer which shown in Figure 4 
and 6b, PG based random copolymers can be successfully synthesized under the same condition as 
glycidol polymerization. The random copolymers synthesized showed a controlled molecular weight 
and relatively low polydispersity (Mw/Mn < 1.7). The DB value was also controlled by varying the 
glycidol ratio. As expected, the solubility property of copolymers rely on comonomer type and their 
structure. While the PG have excellent solubility only in polar solvents, the poly(glycidyl ether) 
homopolymer are soluble in various organic solvents such as THF, toluene and methanol.41 
Random copolymer can also have various functionality depending on comonomer while PG 
homopolymer have only hydroxyl functionality. For example, (i) by using 1,2-isopropylidene glyceryl 
glycidyl ether (IGG), one primary and one secondary alcohol group per monomer can be provided to 
PG backbone after acidic deprotection.39 (ii) The incorporation of amino groups is possible by direct 
copolymerization of N,N-dibenzyl amino glycidol (DBAG), followed by hydrogenolytic deprotection.40 
(iii) By employing allyl glycidyl ether (AGE) or ethoxy vinyl glycidyl ether (EVGE), a controllable 
number of ally ether functionality can be introduced at the PG structure, which give accessibility to 
thiol-ene coupling reaction.38, 42 (iv) By copolymerizing glycidol and glycidyl propargyl ether, multi-
alkyne functional hbPGs can be obtained with one-step synthesis, which can be modified by “click 
reaction” such as the copper-catalyzed azide-alkyn cycloaddition (Figure 6c).37  
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Figure 6. (a) Methods to synthesize functional epoxide monomer and (b) overview of functional 
epoxide monomer. (c) Copolymer of glycidol and glycidyl propargyl ether as an example of 
heterofunctional hbPG and its additional modification by “click reaction”.  
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With recent interest toward degradable polymer, stimuli-degradable PGs and its monomers are 
actively developed by various groups. Frey and co-workers developed pH-degradable hbPG by 
polymerizing acetal bond bearing epoxide monomer with glycidol (Figure 7a). With this method the 
acid-labile acetal linkage can be incorporated into hbPG backbone, which lead to degradation of 
polymer under acidic condition.43 Another approach reported by Kizhakkedathu et al. controlled the 
degradation kinetics of hbPG introduced by incorporating ketal linkages with different structure in to 
polymer backbone, which result from copolymerization of ketal bearing epoxide monomer and glycidol 
(Figure 7b).44, 45 In contrast, our group design and synthesized the redox degradable monomer which is 
disulfide containing epoxide monomer and redox-degradable hbPG by polymerizing redox degradable 
monomer with glycidol, which lead to incorporation of the redox degradable disulfide bond into 
polymer backbone, thus polymer degradation under redox condition (Figure 7c and for detail 
information, see the part 2). 
 
3.3. Further modification strategy 
There are many synthetic method to modify the hydroxyl group of the PG backbone. The hydroxyl 
groups can be converted into enormous kind of functional groups such as ethers,46 esters,47 carbonates,48 
or urethanes49 (Figure 4). Chau et al. reported a library of homo- and heterofunctional polyether polyols 
and its derivatives bearing orthogonal precursors such as azide, allyl, alkynyl and acyl groups for the 
attachment of drugs, imaging agents and biocomolecules.50 
The simplest functionalization method of PG is the methylation of the hydroxyl groups of PG, which 
lead to polarity change. By employing methyl iodide, the hydroxyl groups are changed to methyl 
group.51 Also, the hydroxyl group of PG can be modified via esterification by aliphatic acyl chlorides. 
In addition, acetic acid52 and acetic anhydride53 were employed as reactants for hydrophobically 
modified PG, resulting in poly(glycerol-co-glycerol acetate)s which can have various amount of 
hydroxyl group and LCST behavior (4 to 100 °C). 
A copper-catalyzed alkyn-azide cycloaddition (CuAAC) is widely employed for postpolymerization 
modifications as orthogonal method. Moller et al. converted PG backbone into an alkyne-functionalized 
polymer by using propargyl bromide. With this strategy they investigate the cycloaddition reaction of 
an azido-functional sugar and glycidyl propargyl ether, which aim at hetero-multifunctional 
polyethers.46 
Recently, Haag group modified the hydroxyl group of PG to sulfate groups because they have 
outstanding anti-inflammatory potential and act as active targeting moieties for drug delivery.54 In 
addition, with these sulfate groups they develop the aromatically derivatized hbPG sulfates and 
investigate the structure dependent transport properties. 
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Figure 7. Schematic representation of pH-degradable (a) acetal bearing hbPG and (b) ketal containing 
hbPG, and redox-degradable (c) disulfide containing hbPG.  
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4 Application of PG in various field 
4.1. Biomedical application 
The biggest motivation of the significant interest to PGs is their excellent biocompatibility and various 
synthetic route to their derivatives. This fascinating characteristics could be result from their structural 
similarity to the most biocompatible PEG which is practically applied in biomedical and pharmaceutical 
field to conjugate protein or drug (PEGylation).55 In 2006, the pioneering work which is a comparative 
study observing the biocompatibility of PEG, linPG and hbPG was conducted by Brooks et al.21 Both 
in vivo and in vitro assays showed excellent biocompatibility. Figure 8 demonstrate the excellent 
biocompatibility of PG. These fundamental studies were expanded to high molecular weight PGs, which 
prove the potential of PG for biomedical applications.56-58 In these reasons, hbPG and their derivatives 
have attracted increasing interest for drug-delivery,32, 59, 60 macromolecular therapeutics,61, 62 
proteomics,63 human serum albumin substitutes64 and other biomedical applications. 
  Biocompatible polymers have attracted many interests as drug or protein delivery carriers.60, 65 
Conjugation of an anticancer drug to polymer results in increased drug accumulation in tumor tissues 
which is known as enhanced permeation and retention (EPR) effect, which is result from enhanced 
permeability to the leaky tumor vasculature and the limited lymphatic drainage of polymer-drug 
conjugates.66, 67 The hbPG is very promising candidate as drug delivery carrier due to its many of 
hydroxyl groups, which can give many possibility for chemical modification with drugs and other 
biomolecules.68, 69 In 2012, our group report doxorubicin, anti-cancer drug, conjugated PG for drug 
delivery (Figure 9a).60 This polymer demonstrate efficient conjugation of hydrophobic doxorubicin and 
enhancement of targeting capacity to the solid tumor. In experiment, we confirmed burst release of 
doxorubicin via the cleavage of hydrazone bonds under the acidic condition and its significant 
cytotoxicity to cancer cell. 
  Recently, Haag groups reported new class of polycation which consist of biocompatible PG core and 
star-like oligoamine shell (Figure 9b).70, 71 These polymers carry positive charges at physiological pH 
and have the high biocompatible polyether core unlike polyethyleneimine (PEI) and other polyamines, 
which are used for gene delivery. In addition, these materials shows the excellent transfection/toxicity 
ratio, resulting from the favorable primary amines that is main functions for a high degree of 
siRNA/DNA binding. Due to their excellent biocompatibility, these materials are considered as 
potential candidates for in vivo applications. 
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Figure 8. In vitro cell-viability assays of hbPG, linPG, PEG and hetastarch polymers determined MTT 
assay using L-929 cells at increasing concentrations from left to right: 0.0001, 0.001, 0.01, 0.1, 0.5, 1, 
5, and 10 mg/mL (up to 5 mg/mL for hetastarch). 
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Figure 9. (a) Illustration of drug-polymer conjugate of doxorubicin conjugated poly(ethylene oxide)-
hb-PG  and its self-assembled micelle formation for the pH-responsive intracellular release of anti-
cancer drug. (b) Architecture of polycation which consist of PG core and star-like oligoamine shell and 
its polyplex formation for cellular internalization of DNA/siRNA.  
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In order to develop a synthetic human serum albumin substitute, hbPG was modified with 
hydrophobic C18 alkyl and MPEG-350 chains to form hbPG-C18-PEG.64 These materials can bind 
hydrophobic molecules such as fatty acids, paclitaxel, pyrene in aqueous solution owing to alkylation. 
In addition, in evaluation in animal testing, these materials show excellent biocompatibility and non-
immugenicity with a long and controllable circulation half-life of ~30 h. 
 
4.2. Hyperbranched polyglycerol as a support for a variety of catalysts. 
With purpose for enhancement of catalyst stability and high activity of the catalyst, immobilization of 
analogues onto polymeric supports attract significant attention.72, 73 Catalytically active transition-metal 
complexes functionalized dendrimers and HBP are promising materials regarding to catalyst recovery 
as well as elimination of metal residues after finishing the reaction.74-76 
While dendrimers are synthesized by multiple step and expensive, hbPG can be synthesized on a 
kilogram-scale and bear multiple hydroxyl groups, which can be readily modified by standard reaction 
strategy.9 In addition, its versatile properties, such as high loading capacity (13.5 mmol g-1), chemical 
stability, noncoordinating, and good solubility in various solvents, make it a promising support for 
catalysts. 
Catalytically active dendritic materials can be prepared by fixation at dendritic surface or the 
encapsulation of metal nanoparticles. For guest encapsulation, core amphiphilic hbPGs have been 
successfully employed to encapsulate template palladium nanoparticles of which size is between 2 and 
5 nm by Frey et al. The resulting particles were used for a model hydrogenation reaction of 
cyclohexene.76 In addition, they encapsulated sulfonate group containing hydrophilic pincer platinum(II) 
complexes into amphiphilic hbPGs (Figure 10). The Pt(II) which is non covalently encapsulated in PG 
showed catalytic activity for reaction of double Michael additions without leaching. 
Recently, Haag group reported the hbPG-supported metathesis catalysts where catalytic moieties are 
located at the shell or in core of the dendritic polymer.77 They are considerably robust as well as air 
stable at room temperature for minimum six weeks. The second-generation catalyst which exhibit an 
N-heterocyclic carbine ligand is more active than the first generation Hoveyda-Grubbs catalyst, 
resulting in the formation of di- and trisubstituted olefins with high conversion. Additional treatment of 
activated charcoal after dialysis showed its beneficial for Ru-removal. 
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Figure 10. Illustration of the NCN-pincer platinum(II) catalyst encapsulated in hbPG. 
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4.3. Polymer electrolyte for lithium-ion batteries 
The lone pair of oxygen atoms of ethers allow ether to be relatively strong Lewis base and have high 
donor numbers, thus ether can dissociate lithium salt with strong solvation of cations. To date, 
poly(ethylene oxide) (PEO) has been briskly studied as polymer electrolyte because PEO has ability to 
solvate as well as transport lithium-ions.78 However, PEO is semicrystalline with a high degree of 
crystallization which lead to low-Li-ion conductivity (1 × 10-6 S/cm) under its melting temperature (Tm 
≈ 65 oC).79 This result makes PEO ill-suited as battery electrolyte because this is insufficient for current 
battery applications, which is the target of 1 × 10-3 and require operation at ambient temperatures.80, 81 
In order to decrease the crystallinity of PEO while retaining enhanced conducting, solvating, and 
structural properties, several strategies of PEO modification are reported: (i) Incorporation of propylene 
oxide (PO), which suppress crystallization but cannot substantially improve Li-ion conductivity.82 (ii) 
Grafting oligo(ethylene oxide) to other polymer chain. Comb-branched polymer obtained improve 
conductivity while safety issues are remaining related to the leakages of liquid additives due to its gel-
type systems.82-84 (iii) Branched and cross-linked polymers have been investigated as polymer 
electrolyte,85-87 but conductivities is far below the target of 1 × 10-3 S/cm. In case of hbPG, a Li-ion 
conductivity is 6.6 × 10-6 S/cm.87 
HBPs are known as polymer to frustrate crystallization. Recently, hyperbranched PEO (hbPEO) 
which were synthesized by copolymerization strategy of ethylene oxide (EO) and glycidol (G) were 
developed (Figure 11b).36 The resulting hbPEOs are highly viscous liquids, which lead to almost no 
vapor pressure. Therefore the concerns about leakage and flammability comparing to small molecule 
additive can be decreased. Yoon et al. studied on the Li-ion conductivity of hbPEO and methylated 
hbPEO with varying glycerol branching content,88 which demonstrate that hbPEO bearing the branching 
glycerol moiety of 8 mol % can prevent crystallization in blends with Li-salts, and shows almost 100-
fold increase of the conductivity below 50 oC comparing to PEO. However, it is observed that decreased 
Li-ion conductivity which result from a hydrogen-bonding interaction, leading to lowered molecular 
dynamics. However, transformation of hydroxyl to methyl group increased Li-ion conductivity to 6 × 
10-5 S/cm at ambient conditions (Figure 11c). Measurement of inelastic neutron scattering experiments 
demonstrate the variation of Li-ion conductivities depending on glycerol branching content and 
methylation correlate with segmental dynamics of hydrogen meansquare displacements. 
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Figure 11. (a) Schematic illustration of hbPEO electrolyte for Li-ion battery. (b) Structure and (c) Li-
ion conductivity of hbPEO. 
  
22 
 
Reference 
 
1.  Kim, Y. H.; Webster, O. W., J. Am. Chem. Soc. 1990, 112, 4592-4593. 
2.  Tomalia, D. A.; Frechet, J., John Wiley & Sons, Chichester 2001, 3. 
3.  Flory, P. J., Principles of polymer chemistry. Cornell University Press: 1953. 
4.  Frey, H.; Haag, R., Rev. Mol. Biotechnol. 2002, 90, 257-267. 
5.  Newkome, G.; Moorefield, C.; Vögtle, F., 2001. 
6.  Wurm, F.; Frey, H., Prog. Polym. Sci. 2011, 36, 1-52. 
7.  Hölter, D.; FRET, H., Acta Polym. 1997, 48, 298-309. 
8.  Wilms, D.; Stiriba, S.-E.; Frey, H., Acc. Chem. Res. 2009, 43, 129-141. 
9.  Sunder, A.; Hanselmann, R.; Frey, H.; Mülhaupt, R., Macromolecules 1999, 32, 4240-4246. 
10.  Sunder, A.; Frey, H.; Mülhaupt, R. In Hyperbranched polyglycerols by ring‐opening 
multibranching polymerization, Macromolecular Symposia, Wiley Online Library: 2000; pp 187-196. 
11.  Sunder, A.; Mülhaupt, R.; Haag, R.; Frey, H., Adv. Mater. 2000, 12, 235-239. 
12.  Zalipsky, S., Adv. Drug Del. Rev. 1995, 16, 157-182. 
13.  Roberts, M.; Bentley, M.; Harris, J., Adv. Drug Del. Rev. 2002, 54, 459-476. 
14.  Harris, J. M.; Zalipsky, S.; Chemistry, A. C. S. D. o. P.; Meeting, A. C. S., Poly(ethylene Glycol): 
Chemistry and Biological Applications. American Chemical Society: 1997. 
15.  Harris, J. M., Introduction to biotechnical and biomedical applications of poly (ethylene glycol). 
Springer: 1992. 
16.  Otsuka, H.; Nagasaki, Y.; Kataoka, K., Adv. Drug Del. Rev. 2003, 55, 403-419. 
17.  Veronese, F. M.; Pasut, G., Drug Discovery Today 2005, 10, 1451-1458. 
18.  Barz, M.; Luxenhofer, R.; Zentel, R.; Vicent, M. J., Polymer Chemistry 2011, 2, 1900-1918. 
19.  Calderón, M.; Quadir, M. A.; Sharma, S. K.; Haag, R., Adv. Mater. 2010, 22, 190-218. 
20.  Schömer, M.; Schüll, C.; Frey, H., J. Polym. Sci., Part A: Polym. Chem. 2013, 51, 995-1019. 
21.  Kainthan, R. K.; Janzen, J.; Levin, E.; Devine, D. V.; Brooks, D. E., Biomacromolecules 2006, 7, 
703-709. 
22.  O'brien, R. D., Fats and oils: formulating and processing for applications. CRC press: 2010. 
23.  Mangold, C.; Wurm, F.; Frey, H., Polymer Chemistry 2012, 3, 1714-1721. 
24.  Weinhart, M.; Grunwald, I.; Wyszogrodzka, M.; Gaetjen, L.; Hartwig, A.; Haag, R., Chem. Asian 
J 2010, 5, 1992-2000. 
25.  Wurm, F.; Dingels, C.; Frey, H.; Klok, H.-A., Biomacromolecules 2012, 13, 1161-1171. 
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88.  Lee, S.-I.; Schömer, M.; Peng, H.; Page, K. A.; Wilms, D.; Frey, H.; Soles, C. L.; Yoon, D. Y., 
Chem. Mater. 2011, 23, 2685-2688. 
 
  
26 
 
Part 2. Redox-Degradable Biocompatible Hyperbranched Polyglycerols: 
Synthesis, Copolymerization Kinetics, Degradation, and Biocompatibility 
 
1. Introduction 
Hyperbranched polyglycerols (PGs) are one of the most popular hyperbranched polymers and possess 
a globular polymeric structure that comprise a polyether backbone with a large number of hydroxyl 
groups.1-3 PGs are typically synthesized via ring-opening multibranching polymerization of glycidol 
monomers over a broad range of molecular weights with relatively narrow polydispersities.4,5 Similar 
to its polyether analog, poly(ethylene glycol) (PEG), PG exhibits excellent biocompatibility, 
immunogenicity, and low toxicity.2,6,7 Moreover, owing to their facile synthetic nature and access to 
various architectures8-10 as well as the various functional groups11,12 that can be installed, PGs have 
attracted significant attention as promising candidates for application in biomedical applications,13-15 
including drug delivery systems,16-18 polymer therapeutics,19 proteomics,20 and human serum albumin 
substitutes.21 
The long and controllable in vivo circulation half-lives of PGs results in improved therapeutic 
efficacy;22 for example, PGs with molecular weights of 100 and 500 kg/mol have circulation half-lives 
of 32 and 57 h, respectively.23 However, recent in vivo studies have indicated a tendency for relatively 
high accumulation of higher molecular–weight polymers in organs such as the liver; approximately 10% 
of the injected dose for 500 kg/mol PG accumulated in the liver.23 Therefore, it remains an important 
challenge to develop polymers that are biocompatible and degradable under physiological conditions. 
For this purpose, PGs with acid-degradable moieties were recently introduced. Frey and co-workers 
developed two types of pH-responsive hyperbranched PGs by incorporating acetal bonds into the 
monomer or initiator.24,25 Another approach reported by Kizhakkedathu and co-workers controlled the 
degradation kinetics of hyperbranched PG introduced by incorporating ketal linkages with different 
structures into the polymer backbone.26,27 However, the development of effective polymers that undergo 
pH-responsive degradation remains incomplete as the polymers could degrade in aqueous solutions 
even at a neutral pH condition.  
 
 
 
---------------------------------------------------------------------------------------------------------------------------
Reproduced in part with permission from Son, S.; Shin, E.; Kim, B.-S. unpublished results. Under 
revision for macromolecules.  
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In biological systems, disulfide bonds degrade into their corresponding thiols in response to the 
reduction potential, which is mainly developed by the higher concentration of glutathione (GSH, 2–10 
mM) in cytosol than in the extracellular fluids (<10 μM).28-30 In contrast, disulfides are stable in the 
oxidative environments of the cell exterior because of the higher concentration of cystine over cystein 
and reduced glutathione.31 Such a large concentration gradient between the intracellular and 
extracellular environment offer new opportunities for the development of polymers that selectively 
degrade after uptake into the cells.32,33 Although there have been reports on the utilization of disulfide 
bonds for the degradation of PEG- and PG-containing materials,34-36 many of them are limited to the 
conjugation linkers between polymers and drugs37 and cross-linkers for nanogels;38,39 to the best of our 
knowledge, there are no reports on the use of disulfide bonds within a PG backbone. 
Herein, we present the design and synthesis of novel redox-degradable hyperbranched PGs for the 
first time (Scheme 1). Specifically, a glycerol monomer containing a disulfide bond, i.e., 2-{2-[2-
(oxiran-2-ylmethoxy)ethyl]disulfanyl}ethanol (SSG), was designed and polymerized through anionic 
ring-opening multibranching polymerization to yield a series of redox-degradable hyperbranched 
polyglycerols (PSSGs) with controlled molecular weights (2000–11000 g/mol) and relatively low 
molecular-weight distributions (Mw/Mn < 1.15). In addition, copolymerization with a non-degradable 
glycerol (G) monomer provided P(G-co-SSG) copolymers containing an adjustable fraction of 
degradable moieties within the PG backbones. We also investigated the copolymerization kinetics of G 
and SSG using quantitative in situ 13C NMR spectroscopy. In particular, we characterized the 
degradability of these polymers under redox conditions to elucidate the structures of the polymers after 
degradation. Finally, we demonstrated the superior biocompatibility of the prepared polymers via cell 
viability tests. 
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Scheme 1. Illustration of the Redox-Triggered Degradation of PSSG 
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2. Experimental section 
2.1. Materials 
All reagents and solvents were purchased from Sigma Aldrich and Acros and used as received unless 
otherwise stated. Chloroform-d1 and deuterium oxide were purchased from Cambridge Isotope 
Laboratory. 
 
2.2 Characterization 
1H NMR spectra were acquired using a VNMRS 600 spectrometer operating at 600 MHz using CDCl3 
and D2O solvents. The number- and weight-averaged molecular weights and molecular-weight 
distribution were measured using gel permeation chromatography (GPC, Agilent technologies 1200 
series) with a polystyrene (PS) standard and 0.01 M lithium bromide containing dimethyl formamide 
(DMF) as an eluent at 30 °C with a flow rate of 1.00 mL/min. Electrospray ionization mass spectroscopy 
(ESI-MS) was performed using an HCT Basic System from Bruker with a sample concentration of 0.10 
mg/mL in methanol. Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry 
(MALDI-ToF) measurements were carried out on an Ultraflex III MALDI mass spectrometer. The laser 
system consisted of a pulsed UV laser, an attenuator that allowed fine adjustment of the laser fluence, 
a lens system to focus the laser beam, and a mirror system to direct the beam into the ion source on the 
target plate. The standard was a N2 laser with a 337 nm wavelength (pulse energy of 150 μJ) and 3 ns 
pulse width for use with matrix components that absorb light of this wavelength (IVB product). 2,5-
Dihydroxy-benzoic acid (DHB) was used as the matrix. A 10 g/L solution of the polymer in methanol 
and 10 g/L solution of the matrix solution were prepared separately. The two solutions were then mixed, 
a 1.0 μL aliquot of the mixture was applied to a target plate, and the solvent was evaporated. 
 
2.3. Synthesis of SSG (Monomer) 
A solution of 2-hydroxyethyl disulfide (13.88 g, 0.09 mol) in t-butanol (150 mL) was slowly added to 
a solution of potassium t-butoxide (7.41 g, 0.09 mol) in t-butanol (225 mL) with stirring for 15 min at 
room temperature under argon. After stirring for an additional 15 min, excess epichlorohydrin (54.6 g, 
0.6 mol) was added dropwise over 30 min using a syringe and the solution was stirred at room 
temperature for 15 h. The salt that formed was removed via filtration and the filtrate was removed using 
a rotary evaporator to yield a mixture of the product, byproduct (diepoxide), and unreacted diol. The 
crude product was dissolved in 150 mL of methylene chloride and rinsed with water (30 mL) three 
times. The organic layer was evaporated using a rotary evaporator and dried in a vacuum oven. The 
mixture was further purified using silica gel column chromatography with an ethyl acetate/hexane (2:1 
v/v) eluent to obtain pure SSG monomer as a pale-yellow viscous liquid (6.2 g, 33%). 1H NMR (600 
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MHz, CDCl3): δ ppm 3.90 (dd, 2H, J = 12.1, 6.0 Hz), 3.85–3.73 (m, 3H), 3.39 (dd, 1H, J = 11.7, 6.1 
Hz), 3.19–3.15 (m, 1H), 2.90 (dt, 4H, J = 22.5, 6.1 Hz), 2.82–2.90 (m, 1H), 2.63 (dd, 1H, J = 5.0, 2.7 
Hz) 2.20 (t, 1H, J = 6.3 Hz). 13C NMR (150 MHz, CDCl3): δ ppm 70.91, 68.84, 59.66, 50.19, 43.50, 
40.56, and 37.8. 
 
2.4. Synthesis of poly(2-{2-[2-(oxiran-2-ylmethoxy)ethyl]disulfanyl}ethanol) (PSSG homo-
polymer, Polymer 3) 
Trimethylpropane (TMP) (24 mg, 0.1788 mmol) was placed in a two-neck round -bottom flask. 
Potassiu
methanol and then added to the flask and stirred for 30 min at room temperature under an argon 
atmosphere. Excess methanol was removed using a rotary evaporator and the remaining product was 
dried in a vacuum oven (90 °C, 3 h) to yield a white salt of the initiator. The flask was then purged with 
argon and heated to 90 °C. The SSG monomer (0.70 g, 3.32 mmol) was added dropwise over 12 h using 
a syringe pump. After complete addition of the monomer, the reaction was continued for an additional 
5 h. After dissolving the PSSG polymer in 1.0 mL of methanol, the homogeneous polymer solution was 
precipitated into excess diethyl ether and washed twice with diethyl ether. The resulting polymer was 
dried under vacuum at 90 °C for one day. The Mn of polymer 3 was 3709 g/mol, as calculated from the 
NMR data shown in Figure 2b using the following equation: Number of repeating units (n) = 22 
(integration value) × 3 (number of protons in TMP (methyl, 3H)) / 4 (number of protons neighboring 
the disulfide moiety of SSG (4H)) = 17; Mn = 210.31 (molecular weight of the SSG monomer) × 17 + 
134.17 (molecular weight of the TMP initiator) = 3709.44 g/mol.  
 
2.5. Synthesis of poly(glycerol-co-2-{2-[2-(oxiran-2-ylmethoxy)ethyl]disulfanyl}ethanol) (P(G-co-
SSG) copolymer, Polymer 8) 
TMP (24 mg, 0.1788 mmol) was placed in a two-neck round bottom flask. Potassium methoxide in 
flask and stirred for 30 min at room temperature under an argon atmosphere. Excess methanol was 
removed using a rotary evaporator and the resultant product was dried in a vacuum oven (90 °C, 3 h) 
to yield a white salt of the initiator. The flask was purged with argon and heated to 90 °C. A mixture of 
SSG (0.757 g, 3.6 mmol) and glycidol (G) (0.133 g, 1.8 mmol) was added dropwise over 12 h using a 
syringe pump. After complete addition of the monomer, the reaction was continued for an additional 5 
h. The resulting P(G-co-SSG) polymer was dissolved in 1.0 mL of methanol; the homogeneous polymer 
solution was then precipitated into excess diethyl ether and the precipitate was washed twice using 
diethyl ether. The resulting polymer was dried under vacuum at 90 °C for one day. The Mn of polymer 
8 was 4424 g/mol, as calculated from the NMR data shown in Figure 2c using the following equation: 
Number of repeating units (SSG) = 17.47 (integration value) × 3 (number of protons of TMP (methyl, 
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3H))/4 (number of protons neighboring the disulfide moiety of SSG (4H)) = 13, number of repeating 
units (G) = [75.52 (integration value) × 3 (number of protons of TMP (methyl, 3H)) – {(13 (number of 
SSG repeating units) × 9 (number of protons of SSG except those that neighbor the disulfide moiety 
(9H))) – 6 (number of protons of TMP (ether, 6H))}] / 5 (number of protons of the G monomer (5H)) 
= 21; Mn = 74.08 (molecular weight of the G monomer) × 21 + 210.31 (molecular weight of the SSG 
monomer) × 13 + 134.17 (molecular weight of TMP) = 4423.88 g/mol. 
 
2.6. Polymer degradation 
The degradation of PSSG through disulfide reduction was studied using NMR spectroscopy and GPC 
as follows: For the NMR analysis, the redox-dependent degradation of the polymers was studied by 
comparing the chemical shift values before and after treatment with a solution of two equivalents 
(against disulfide bond in polymer backbone) of dithiothreitol-d10 (DTT-d10)–containing D2O. For the 
NMR study, approximately 15 mg of the PSSG polymer was dissolved in 0.60 mL of the DTT solution. 
The reduction of disulfide and degradation of the polymers was monitored by 1H and 13C NMR 
spectroscopy, respectively. For the GPC analysis, DTT (two equivalents of the disulfide) was added to 
a solution of P(G-co-SSG) in DMF, and the sample was analyzed using GPC-MALLS in DMF 
containing 10 mM lithium bromide. The molecular weights (i.e, Mn and Mw) and PDI were measured, 
and the results before and after DTT treatment were compared. 
 
2.7. 13C NMR kinetics 
To generate the initiator, methoxyethanol (0.5 g, 6.57 mmol) and cesium hydroxide monohydrate (0.378 
g, 2.25 mmol) were reacted in a round-bottom flask under an argon atmosphere at 60 °C. The initiator 
solution and G and SSG comonomers were placed in a 4.0 mL vial and stirred over an ice bath. The 
mixture was transferred to a conventional NMR tube under an argon atmosphere and then sealed with 
a septum over an ice bath. The kinetic measurements using 13C NMR spectroscopy were recorded on a 
600 MHz VNMRS system with a 5 mm PFG AutoX DB probe in neat solutions. A standard kinetic 13C 
NMR experiment required 64 transients that were obtained with a 13.7 μs 90° pulse, spectral width of 
1894 Hz, and recycling delay of 10 s for each kinetic run; 70 experiments were performed over a period 
of 13 h with a flip angle of 45° and inverse gated decoupling. 
 
2.8. Cytotoxicity assay 
Human epithelial carcinoma cells (HeLa) and human diploid cells (WI-38) were purchased from the 
Korean Cell Line Bank (Seoul, Korea). Cytotoxicity assays were performed using the traditional MTT 
assay. Cells were seeded in 96-well plates at a density of 7 × 103 cells per well and incubated for 24 h 
in 5% CO2 at 37 °C. HeLa cells were cultured with Dulbecco’s Modified Eagle’s Medium (DMEM; 
Life Technologies) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. WI-38 cells 
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were incubated in Roswell Park Memorial Institute (RPMI) 1640 media (Life Technologies) with 10% 
FBS, 25 mM sodium bicarbonate, and 1% penicillin-streptomycin. After removing the culture medium, 
the wells were washed with PBS. Each well was then refilled with 90 μL of fresh media and 10 μL of 
various concentrations of PG150, P(G60-co-SSG30), and PSSG20 solutions and incubated for an additional 
24 h. For the MTT assays, each well was washed with PBS and then filled with 10 μL of thiazolyl blue 
tetrazolium bromide (MTT; Sigma-Aldrich) stock solution (5 mg/mL) and 90 μL of fresh media. After 
incubation for 4 h, 100 μL of DMSO was added to the polymer solution to solubilize the MTT-formazan 
product, and the plates were gently agitated for 15 min at room temperature. The absorbance of the 
solution was recorded at a wavelength of 540 nm using 620 nm as the reference. For the CCK-8 assays, 
each well was washed with PBS and then filled with 10 μL of water-soluble tetrazolium salt (CCK-8; 
Dojindo Molecular Technologies) and 90 μL of fresh media. After incubation for 4 h, the plates were 
gently agitated for 15 min at room temperature and the absorbance of the solution was recorded at a 
wavelength of 450 nm.  
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3. Results and discussion 
3.1. Polymer synthesis and characterization 
To produce redox-degradable and multi-functional hyperbranched polyglycerol, we first designed and 
synthesized a redox-labile AB2-type monomer, i.e., SSG (Figure 1a). In the SSG monomer, the disulfide 
bond is a redox-labile linkage and the hydroxyl group plays a role as a branching reaction site. The 
disulfide linkage was introduced between epoxide and hydroxyl groups using 2-hydroxyethyl disulfide, 
as shown in Figure 1a. The successful synthesis of the monomer SSG was confirmed via 
characterization using 1H and 13C NMR spectroscopy (Figures 2). 
After successful synthesis of the SSG monomer, we studied their anionic ring-opening 
multibranching polymerization using a potassium alkoxide initiator that was formed via the reaction of 
TMP and potassium methoxide solution (Figure 1). As demonstrated in previous works, we employed 
a slow monomer addition method to synthesize the polymers in a controlled manner.10,16,17 The 
molecular weights of the polymers were controlled via the monomer-to-initiator ratio and characterized 
using GPC and 1H NMR spectroscopy. In all cases, controlled molecular weights (PSSG homopolymer: 
2200–10600 g/mol, P(G-co-SSG) copolymer: 5000–24000 g/mol) and narrow molecular-weight 
distributions (Mw/Mn: <1.15 for the homopolymer, <1.38 for the copolymer) were obtained considering 
the branched structures of the products and the PS standard used (Table 1). Interestingly, we observed 
that the SSG monomer converted completely for the homopolymer (90–100%); however, the addition 
of glycidol as a comonomer slightly decreased the SSG conversion (60–85%). This result suggests 
different reactivity of the two monomers, which will be described in detail in the following discussion. 
In addition, by varying the feed composition of SSG (25–75 mol%) in the polymerization of the P(G-
co-SSG) copolymers, we achieved various compositions of P(G-co-SSG) with incorporation ratios of 
SSG ranging from 28 to 55 mol%. 
All synthesized PSSG and P(G-co-SSG) polymers were soluble in water and organic polar solvents 
such as methanol, DMSO, and DMF. As shown in Figure 3a, the 1H NMR spectra of the homopolymer 
(polymer 3) clearly showed the characteristic peaks corresponding to the protons on the carbon atoms 
adjacent to the disulfide moiety (peaks d and e at 2.8–3.1 ppm), the methyl and methylene groups of 
TMP (peaks a and b at 0.8 and 1.3 ppm, respectively), and polyether backbone (polyether backbone of 
PSSG and peak c at 3.4–4.2 ppm). By determining the ratio of the integrals of the peaks for the initiator 
(0.8 ppm) to the protons on the carbon atoms that neighbor the disulfide moiety (2.8–3.1 ppm), we 
calculated the Mn values (see the experimental section for detailed calculations). Overall, we found good 
agreement between the target molecular weight and the data obtained from NMR spectroscopy. 
Moreover, the 1H NMR spectrum of the copolymer (polymer 8) shows similar chemical shifts as 
that of the homopolymer (Figure 3b). However, the polyether backbone signal (3.4–4.2 ppm) was much 
more intense for the copolymer than for the homopolymer, which was attributed to the additional  
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Figure 1. Synthetic pathways for the preparation of (a) redox-active disulfide monomer (SSG) and (b) 
polymers from pure SSG monomers to yield the PSSG homopolymer and from SSG and glycerol 
monomers (G) to generate the P(G-co-SSG) copolymer. 
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Table 1. Characterization data for all polymers synthesized in this study 
 
aDetermined via 1H NMR spectroscopy. bMeasured using GPC-RI in DMF with a polystyrene standard. 
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Figure 2. (a) 1H NMR and (b) Inverse-gated 13C NMR spectrum of SSG monomer in CDCl3. 
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Figure 3. 1H NMR spectra of (a) PSSG homopolymer (polymer 3) in D2O and (b) P(G-co-SSG) 
copolymer (polymer 8) in D2O. 
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polyether backbone present in PG. The incorporation ratio of SSG and the molecular weight were 
calculated by integrating the peaks of the protons on the carbon atoms adjacent to the disulfide moiety 
at 2.8–3.1 ppm (SSG) and on the polyether backbone at 3.4–4.2 ppm against the signal of the initiator 
at 0.8 ppm (see the experimental section for detailed calculations). 
In addition, to confirm the branched structure of the PSSG polymers, we employed 1H NMR and 
inverse-gated 13C NMR. In addition, we compare these results with spectrum anticipated from 
MestReNova which is famous software for NMR data expectation (Figure 4 and 5). With this software, 
we assigned all of peaks in 1H and 13C NMR spectrum (Figure 4 and 5). From these results, we confirm 
that SSG monomers can be reacted to both L1,3 and L1,11. On the other hands, representative peaks for 
dendritic part could not be found because SSG monomer is too big to recognize both reaction site. 
However, since NMR result clearly shows that SSG is polymerized with both of two reaction site, we 
convince that PSSG has branched structure like conventional PG system. 
The GPC results showed a monomodal distribution and controlled molecular weight values (Table 
1). However, there was a discrepancy between the molecular weights determined by NMR spectroscopy 
and GPC; this was explained by the branched architecture and presence of multiple hydroxyl functional 
groups40 because these globular hyperbranched structures do not contribute to the overall hydrodynamic 
radius of the polymers. Calibration of GPC with PS could be another source of deviation. 
The presence of the TMP initiator and functional monomer segments in PSSG and P(G-co-SSG) 
polymers was clearly confirmed via MALDI-ToF spectroscopy (Figure 6). As shown in Figure 6a, two 
distribution modes were observed because of the coordination of different ions, such as H+ and K+. For 
example, the main molecular weight peak at 1224.82 g/mol corresponded to the molecular weight of 
PSSG with potassium as a counterion (TMP(134.17) + SSG(210.31) × 5 + K+(39.1)), and the peak at 
1186.72 g/mol corresponded to the molecular weight of PSSG with H+ as a counterion (TMP(134.17) 
+ SSG(210.31) × 5 + H+(1)). In addition, the spacing between the signals (210.31 g/mol) matched well 
with the functional SSG unit incorporated into PSSG, which confirmed the presence of the SSG 
monomer. Unlike the PSSG homopolymer results, the MALDI-ToF results for the P(G-co-SSG) 
copolymer revealed the presence of complex distribution modes. As shown in Figure 6b, the TMP-
initiated copolymer of G and SSG was clearly generated. In particular, the peaks that corresponded to 
the copolymer with various combinations of G and SSG were isolated from the complex mass spectrum 
(inset in Figure 6b); for example, the mass peak at 2670.63 g/mol corresponded to the copolymer with 
TMP as an initiator, 11 units of G, 8 units of SSG, and K+ as a counterion (TMP(134.17) + G(74.08) × 
11 + SSG(210.31) × 8 + K+(39.1)). It should be noted that the spacing of the signals corresponded to 
the mass of a linear combination of the respective monomers in the copolymer (G: 74.08 g/mol, SSG: 
210.31 g/mol) in varying degrees, which unambiguously demonstrated the successful copolymerization 
of P(G-co-SSG). 
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Figure 4. (a) Data comparing 1H NMR spectrum (brown) measured from PSSG20 and 1H NMR 
spectrum predicted by MestReNova (blue). Drawn polymer structure has all of polymer part such as 
terminal, linear1,3, linear1,11, dendritic region. (b) Detailed 1H NMR spectrum and peak assignment. 
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Figure 5. (a) Data comparing 13C NMR spectrum (brown) measured from PSSG20 and 13C NMR 
spectrum predicted by MestReNova (blue). Drawn polymer structure has all of polymer part such as 
terminal, linear1,3, linear1,11, dendritic region. (b) Detailed 13C NMR spectrum and peak assignment. 
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Figure 6. MALDI-ToF spectra of the (a) PSSG10 homopolymer (polymer 2) and (b) P(G10-co-SSG20) 
copolymer (polymer 8) using DHB as a matrix. The inset in Figure 3b shows the detailed molar mass 
and assignments of the copolymer in the range of 2600–2700 g/mol. The spacing of the signals 
corresponds to the mass of a linear combination of the respective monomers in the homopolymer and 
copolymer (G: 74.08 g/mol, SSG: 210.31 g/mol). 
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3.2. In Situ copolymerization kinetics 
As we developed the novel SSG monomer, it was essential to investigate its copolymerization behavior 
with other monomers for analysis of the comonomer distribution during the copolymerization. To 
observe the kinetics of the epoxide monomer, online 1H NMR spectroscopy is generally employed as it 
is readily accessible with an interval as short as a few seconds between two spectra and is a quantitative 
method of monitoring the consumption of comonomers.12,40,41 However, the 1H NMR signals of both 
monomers and the polymer overlapped in our case, which limited the monitoring of monomer 
consumption. Therefore, we employed quantitative and in situ monitoring of both monomers for bulk 
copolymerization based on 13C NMR spectroscopy according to a recent development reported by Frey 
and co-workers.42 Specifically, copolymerization of G and SSG was conducted without any solvent at 
50 °C in a conventional NMR tube. During bulk polymerization, a quantitative 13C NMR spectrum 
could be obtained within a few minutes because of the sufficient natural abundance of 13C isotope. With 
this method, we could observe the microstructure of the growing polymer at any time during the reaction.  
Figure 7a shows a typical series of 13C NMR spectra collected during the copolymerization of G and 
SSG that demonstrate the consumption of both monomers (G highlighted in blue and SSG in red) with 
the concomitant appearance of the polyether backbone of the polymers at 70–78 ppm. To assess the 
monomer consumption, the resonances for the representative carbon in the methine group for both 
epoxide monomers (at 55 and 53 ppm for G and SSG, respectively) were compared during the reaction. 
As shown in Figure 7a, the time required for full monomer consumption of G was shorter than that of 
SSG: The signals for the G and SSG monomers could not be detected after 165 and 440 min, 
respectively, which indicated the different reactivity of each monomer. This difference was attributed 
to the structure of the disulfide spacer within SSG, which would hinder the approach of another SSG 
monomer, thus reducing the reactivity of SSG during polymerization, as has been similarly observed in 
other studies.27 Meanwhiles, we chose 50 °C for the polymerization temperature in the kinetics study 
to prevent any potential explosion in the NMR tube caused by the low flash point of the glycidol 
monomer (66 °C). We believe that the polymerization temperature could affect the overall reaction rate; 
however, the relative reactivity of each monomer should remain constant at different temperatures.12,40 
The monomer conversion ratio of both G and SSG monomers were plotted against the total 
conversion ratio during copolymerization, as shown in Figure 7b. It should be noted that the monomer 
conversions in the first 13C NMR spectra were set to 0% and the conversion ratio was calculated from 
the integration values of methine group of each monomer against the signal of the two carbon atoms 
adjacent to the disulfide moiety, which remained constant during polymerization. As shown in Figure 
7b, the molar ratio of SSG units in the polymer chain was considerably lower than the monomer feed 
during the initial stage and increased rapidly upon consumption of the G monomer near the final stages 
of the reaction; for instance, at a total conversion of 51%, the conversions of G and SSG were 80 and 
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22%, respectively (i.e., G is 3.6 times more reactive than SSG). Thus, there is a gradient of monomer 
incorporation during copolymerization of P(G-co-SSG). Nonetheless, unlike the one-pot reaction in 
bulk during NMR measurements, we employed a slow monomer addition method to synthesize the 
copolymers. Thus, we predicted that the difference in the reactivity of the two monomers would be 
suppressed, resulting in more uniform distribution of both monomers. 
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Figure 7. (a) 13C NMR spectra of the in situ copolymerization kinetics of G and SSG (monomer ratio 
1:1). (left) Overlay of the spectra collected within a designated time period. (right) Magnified spectra 
showing the signals for the methine carbons of the epoxide at 53 and 55 ppm, which correspond to the 
G and SSG monomers, respectively (no solvent, 150 MHz, 323 K). (b) Monomer conversion percentage 
versus total conversion for copolymerization of G (blue squares) and SSG (red circle) (monomer ratio 
of 1:1) determined from quantitative 13C NMR kinetics in bulk at 50 °C. 
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3.3. Degradation study 
The presence of disulfide groups in the monomer and polymer chains makes them degradable under 
reductive conditions. DTT was employed as a reducing agent for the following reasons: It has a high 
disulfide reduction efficiency because of its conformational tendency for the formation of a stable six-
membered ring containing an internal disulfide bond, and it is soluble in various organic solvents that 
can dissolve the PG-based polymer. To study the DTT-induced degradation of PSSG (Figure 8a), we 
initially observed the reduction of PSSG by dissolving it in two equivalents (against disulfide bond in 
polymer backbone) of a DTT-d10–containing D2O solution and compared the 1H and 13C NMR spectra 
before and after DTT treatment. As shown in the 1H and 13C NMR results, the signals corresponding to 
the protons and carbon atoms that neighbor the disulfide moiety disappeared with the concomitant 
appearance of thiol-neighboring proton and carbon signals upon DTT treatment (Figure 8b). In addition, 
we confirmed the rapid cleavage of the disulfide bond of polymer chain in a DTT-containing aqueous 
solution within 10 min; this was attributed to the high solubility of PSSG and DTT in water, which 
facilitated the access of DTT to the polymer chains. 
We further investigated the degradation products of the copolymer by GPC analysis. Figure 9 shows 
how the molecular weight of the P(G165-co-SSG55) chain changes after DTT-induced degradation in 
DMF for 1 h. As shown in Figure 9a, the molecular weight peak at 18000 g/mol shifted to the left, 
indicating the successful degradation of P(G165-co-SSG55) into small polymer fragments represented by 
three peaks centered at 2600, 4600, and 12900 g/mol which correspond to small, large and large core 
segment in Figure 9b. We also proposed possible mechanisms for the degradation of polymers from the 
differences that were evident during the polymerizations (Figure 9c). Specifically, the incoming 
monomer resulted in growth of polymer chains via a reaction with either the secondary or primary 
hydroxyl groups, which are represented as blue and green, respectively. If a monomer reacted with the 
secondary hydroxyl group, the generated polymer chain would remain even after DTT treatment. In 
contrast, if the monomer reacted with the primary hydroxyl group, the new polymer chains could be 
cleaved from the parent polymer chain. Accordingly, the degradation products were divided into small 
and large segments; the molecular weights of the large segments were almost twice those of the small 
segments. The presence of the large core segment was attributed to the TMP initiator bearing three 
hydroxyl groups. In theory, the TMP initiator could have three large segments, which would result in a 
larger segment with a molecular weight that was three times that of a large segment. In short, the 
degradation products were divided into three structures because of the initiator and the two different 
reaction sites of the monomer. It is also interesting to note that three peaks in GPC elugram had different 
intensities, which correspond with our expectation shown in Scheme 1 where we employ PSSG 
homopolymer for easy understand. Scheme 1 clearly shows three kinds of degradation product such as 
small segment (one monomer), large segment (more than two monomer) and large core segment and 
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the number of three degradation product are 8, 4 and 1, respectively. Thus, the number of three 
degradation product shows similar tendency with three GPC peaks. 
 
3.4. Biocompatibility assay 
We evaluated the cytotoxicity of PG150, P(G60-co-SSG30), and PSSG20 to investigate their potential as 
drug delivery carriers. Each polymer was treated with WI-38 (human diploid cells) and HeLa (human 
epithelial carcinoma cells) cell lines as models of normal and cancer cells, respectively. The cytotoxicity 
of each sample was examined using MTT and CCK-8 assays, which are commonly used for in vitro 
cytotoxicity testing of polymers and nanomaterials. The MTT assay is based on mitochondrial 
dehydrogenase activity, whereas the CCK-8 assay uses an electron mediator, i.e., 1-methoxy 
phenazinium methylsulfate (1-methoxy PMS), to detect the activity of dehydrogenase, NAD(H), and 
NADP(H) in the cell. Therefore, the CCK-8 assay is more sensitive than the MTT assay as it reflects 
the overall cell viability while the MTT assay shows mitochondrial activity.43 As shown in Figure 10, 
the cell viability of each cell line treated with various concentrations of polymer solution was greater 
than 90% up to a concentration of 100 μg/mL in both assays. Although pure PG displayed superior cell 
viability at all concentration ranges tested, as demonstrated in other reports,6 pure PSSG20 exhibited 
relatively low cell viability as compared to the other two samples at a high concentration of 1000 μg/mL; 
this was due to degradation of the disulfide bond under intracellular redox conditions, which affected 
the intracellular redox mechanism resulting in moderate cytotoxicity. In general, the P(G60-co-SSG30) 
copolymer with 30 mol% disulfide linkages exhibited a higher cell viability than homopolymer PSSG20 
at 1000 μg/mL. Together, these results corroborated that the number of degradable linkages influenced 
the overall cell viability. It should be also noted that P(G60-co-SSG30) contained more degradable 
linkages than previously reported degradable polymers, which contained between 6 and 15 mol% 
degradable linkages.26 Considering that the desired concentration for biological application of these 
polymers is typically lower than 1000 μg/mL, both the homopolymer and copolymer with the novel 
redox-degradable SSG moieties would have minimal adverse effects on the mitochondrial activity and 
cell viability. 
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Figure 8. (a) Illustration of degradation of the PSSG chain upon DTT treatment and (b) corresponding 
changes in the 1H and 13C NMR spectra of the PSSG homopolymer (polymer 3) after DTT treatment 
(10 min). 
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Figure 9. (a) GPC traces of P(G165-co-SSG55) (polymer 5) before (black curve) and after (red curve) 
DTT treatment. The number on the trace represents the corresponding molecular weight of the peak. (b) 
Illustration of the degradation products and (c) possible mechanism for the origin of the three peaks in 
the GPC trace after DTT treatment. The direction of the incoming monomer into the two different 
hydroxyl groups determines the structures of the degradation products. 
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Figure 10. In vitro cell-viability assays of PG150 (black), P(G60-co-SSG30) (grey), and PSSG20 (white) 
polymers determined by (a, b) MTT and (c, d) CCK assays using (a, c) WI-38 (normal cell) and (b, d) 
HeLa (cancer cell). 
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4. Conclusion 
In summary, we reported the design and synthesis of novel redox-degradable hyperbranched 
polyglycerols (PSSGs) from a disulfide-bearing glycerol monomer (SSG). A series of well-defined 
PSSG homopolymers and P(G-co-SSG) copolymers was successfully synthesized via anionic ring-
opening multibranching polymerization of SSG and G resulting in controlled molecular weights and 
molecular weight distributions. The copolymerization kinetics were evaluated using quantitative in situ 
13C NMR kinetic measurements on the bulk sample; the results showed that G was more reactive than 
SSG, leading to a slight gradient during the copolymerization process. Furthermore, we explored the 
redox-responsive degradation of the polymers upon treatment with a reducing agent, which resulted in 
selective degradation of the polymers into small segments. In vitro cytotoxicity studies, such as MTT 
and CCK-8 assays, revealed the superior biocompatibility of these novel polymers even at high 
concentrations (500 μg/mL). We anticipate that this new class of redox-labile polymer will contribute 
to the advancement and understanding of PG-based polymers and be a promising candidate for 
emerging materials and biomedical applications. 
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Part 3. Light-Responsive Micelles of Spiropyran Initiated 
Hyperbranched Polyglycerol for Smart Drug Delivery 
 
 
1. Introduction 
Over the past few decades, drug delivery systems have advanced to achieve time-controlled and site-
specific delivery of therapeutic agents to enhance the efficacy of drugs while minimizing undesirable 
side effects.1,2 Self-assembled nanostructures have long been exploited as potential drug delivery 
carriers, including liposome, dendrimer, micelle, and artificial DNA.3,4 In particular, self-assembled 
polymeric micelles have been highlighted as promising vehicles based on their distinctive features, such 
as high loading capacity, and enhanced solubility and circulation lifetime of active therapeutics, as well 
as prioritized accumulation at tumor sites owing to the enhanced permeability and retention (EPR) 
effect.5-7 More importantly, the high tunability of their chemical and physical properties based on the 
choice of monomer, polymerization degree, architecture, and other parameters, makes self-assembled 
polymeric micelles among the top choices as prospective carriers.8 
Despite the advantages of self-assembled polymeric micelles, the sophisticated delivery of active 
therapeutics in a time-specific and stimuli-specific manner continues to be a challenging endeavor. To 
meet this objective, smart drug delivery carriers that encapsulate drugs and release them at a targeted 
region in response to external stimuli such as pH, light, redox, temperature, and biological stimuli have 
been actively studied.9-11 For example, Zhao and co-workers have extensively investigated the 
development of light-responsive micelle systems owing to the feasibility of remote triggering of active 
therapeutic release and high controllability over the drug release profile using a specific wavelength of 
light. Along the same line, various light-responsive smart delivery systems have been reported to date 
that operate on the principle of photoisomerization, photoinduced cleavage of the photochromic moiety 
or junction, and reversible photo-cross-linking.12-15 
 
 
 
 
 
 
---------------------------------------------------------------------------------------------------------------------------
Reproduced in part with permission from Son, S.; Shin, E.; Kim, B.-S. Biomacromolecules 2014, 
15, 628-634. Copyright 2014 American Chemical Society.   
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As an alternative to traditional poly(ethylene glycol) (PEG), which is the most biocompatible 
synthetic polymer, its polyether analogue, hyperbranched polyglycerol (hb-PG), is actively investigated 
owing to its excellent biocompatibility and advantages over PEG, such as the ease of synthesis, 
controllable structure, multi (or hetero)-functional groups, and oxidation stability.16-19 The recent 
synthetic advancement by the Frey group has allowed the development of well-defined and complex 
architectures of polyglycerols with relatively low polydispersity.17,20 These polyglycerols also exhibit 
flexibility of the physicochemical properties by the protected monomer, variation of initiators, and 
combination with other polymerization techniques.21-23 Recently, polyglycerols with varying 
architectures have been designed and synthesized for biomedical applications. Brooks and co-workers 
have studied the suitability of hydrophobically functionalized hyperbranched polyglycerols for use as 
synthetic albumin substitutes and general drug delivery vehicles.24 In addition, our group has recently 
employed various architectures of the hb-PG in pH-responsive smart drug delivery systems.25,26 
However, there is no report in which the hb-PG is utilized in light-responsive drug delivery systems. 
In this article, we present the design of photoresponsive micelles using spiropyran (SP) initiated 
hyperbranched polyglycerols (SP-hb-PG) and investigation of their potential in light-controlled release 
of model therapeutics (Scheme 1). Among the class of synthetic photoresponsive molecules, SP, a well-
known photochromic molecule, was employed owing to its unique tunability, stability, and fast response 
time.27 Specifically, SP can undergo a reversible transformation from colorless to pink colored 
merocyanine (MC) upon UV irradiation with a marked increase in the polarity associated with the 
structural conversion from neutral to charge separated zwitterions.28 This solubility switching of SP 
from hydrophobic to hydrophilic can induce the destabilization of polymeric micelles of SP-hb-PG into 
individual chains (Scheme 1). Moreover, this destabilization induces controlled release of model 
hydrophobic therapeutics by UV irradiation.  
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Scheme 1. Illustration of light-responsive micelle assembly and disassembly of spiropyran-
hyperbranched-polyglycerol (SP-hb-PG). Micelle structure is not drawn to scale.  
 
 
 
 
  
56 
 
2. Experimental section 
2.1. Materials 
All reagents and solvents were purchased from Sigma Aldrich and Acros unless otherwise stated. Dry 
solvents purchased from Sigma-Aldrich were stored over molecular sieves. Deuterated DMSO-d6 was 
purchased from Cambridge Isotope Laboratory, dried, and stored over molecular sieves. 
 
2.2. Characterization. 
1H NMR spectra were acquired using a 400-MR DD2 spectrometer operating at 400 MHz, using 
DMSO-d6 as a solvent. Gel permeation chromatography (GPC) was performed on a Tosoh HLC-8120 
GPC equipped with a consecutive polystyrene gel column (TSK-GEL GMHHR-M and GMHHR-N) at 
40 °C, using N-methylpyrrolidone containing 0.01 mol/L lithium bromide as an eluent at a flow rate of 
1.0 mL/min; standard polystyrene samples were used for calibration in order to measure the number- 
and weight-averaged molecular weight (Mn and Mw). Matrix-assisted laser desorption and ionization 
time-of-flight mass spectrometry (MALDI-ToF) measurements were carried out on an Ultraflex III 
MALDI mass spectrometer. The laser system consisted of a pulsed UV laser, an attenuator that allowed 
the fine adjustment of the laser fluence, a lens system to focus the laser beam, and a mirror system to 
direct the beam into the ion source on the target plate. The standard was a N2 laser with 337 nm 
wavelength (pulse energy of 150 μJ) and 3 ns pulse width for use with matrix components absorbing 
light of this wavelength (IVB product). Alpha-cyano-4-hydroxycinnamic acid (CHCA) was used as a 
matrix. A 10 g/L solution of the polymer in methanol and a 10 g/L solution of the matrix solution were 
prepared separately. The two solutions were then mixed and a 1 μl aliquot of the mixture was applied 
to a target plate, and the solvent was evaporated. The morphology of the SP-hb-PG micelle was 
investigated using transmission electron microscopy (TEM, JEM-2100, JEOL, Japan) and atomic force 
microscopy (AFM, Dimension 3100, Veeco, USA). Size distribution analysis of the SP-hb-PG micelles 
was performed using dynamic light scattering (DLS, BI-APD, Brookhaven Instrument, New York, 
USA). UV/vis spectrophotometer (UV-2550, Shimadzu) was used to measure absorbance of SP-hb-PG. 
UV irradiation was conducted using a UV lamp (B-100AP high-intensity UV lamp, 100 W). 
 
2.3. Synthesis of a Spiropyran Derivative 
2-(3',3'-Dimethyl-6-nitro-3'H-spiro[chromene-2,2'-indol]-l'-yl)-ethanol (spiropyran) was prepared 
according to the method reported in the literature.29 
 
2.4. Polymerization of SP-hb-PG 
SP (1 mmol) and cesium hydroxide monohydrate (0.8 mmol, 0.8 equiv) were placed in a Schlenk flask, 
benzene (20 wt%) was added, and the mixture was stirred for 2 h at 60 °C under nitrogen atmosphere 
to produce cesium alkoxide. The initiator was dried in a vacuum oven for 2 h at 90 °C. After the initiator 
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became powdery, dry diglyme (ca. 20 wt %) was added under nitrogen atmosphere. Glycidol (30 mmol) 
diluted with dry diglyme (20 wt %) was then added over 12 h at 90 °C using a syringe pump. The 
reaction was terminated by addition of excess methanol and acidic cation exchange resin. After 
dissolving the polymer in methanol, the homogeneous polymer solution was precipitated and filtered 
into excess cold diethyl ether. The resulting material was dried under vacuum at 60 °C for 2 days. 
 
2.5. Preparation of SP-hb-PG Micelle 
A 1.0 mg sample of SP-hb-PG was dissolved in 1 ml of DMF, after which 4 ml of water was added 
dropwise over 1 h via a syringe pump to form micelles. Subsequently, the polymer solution was dialyzed 
against DI water for 2 days to exchange the residual DMF. The solution was then filtered through a 
0.22-μm syringe filter before DLS, TEM, and AFM analysis. 
 
2.6. Pyrene Fluorescence Measurement and CMC Study 
1.0 mg of SP-hb-PG polymer was dissolved in 1.0 ml of DMF. A 10 μl solution of pyrene (5.2 mg/L in 
DMF) was added to the SP-hb-PG solution and the mixture was stirred for 30 min at room temperature. 
5 mL of DI water was then added to the solution at a rate of 0.5 ml/min using a syringe pump. The 
fluorescence of each pyrene-containing polymer micelle solution (with different concentrations) was 
measured at an emission wavelength of 372 nm using a fluorometer. The critical micelle concentration 
(CMC) values were determined by calculating the ratio of the fluorescence intensities at wavelengths 
of 339.06 and 332.04 nm. 
 
2.7. Cytotoxicity Assay 
Human epithelial carcinoma cells (HeLa) and human diploid cells (WI-38) were purchased from the 
Korean Cell Line Bank (Seoul, Korea). Cytotoxicity assay was performed using the traditional MTT 
assay. Cells were seeded in 96-well plates at a density of 1 × 104 cells per well and incubated for 24 h 
in 5% CO2 at 37 °C. HeLa cells were cultured with Dulbecco’s Modified Eagle’s Medium, (DMEM, 
life technologies) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. WI-38 cells were 
incubated in Roswell Park Memorial Institute (RPMI) 1640 media (Life Technologies) with 10% FBS, 
25 mM sodium bicarbonate, and 1% penicillin-streptomycin. After removing the culture medium, the 
wells were washed with PBS. Each well was then refilled with 90 μl of fresh Dulbecco’s Modified 
Eagle’s Medium (DMEM) and 10 μl of SP-hb-PGn polymeric micelle solution. After an additional 24 
h of incubation, thiazolyl blue tetrazolium bromide (MTT, Sigma-Aldrich) was added to each well of 
the cells (final conc. 0.5 mg/mL) and incubation was performed for 4 h. A solution of 100 µl of DMSO 
was replaced with SP-hb-PG solution to solubilize the MTT-formazan product, and the sample was 
incubated for a further 15 min at room temperature. The absorbance of the solution was read at 
a wavelength of 540 nm. 
58 
 
3. Results and discussion 
3.1. Synthesis and Characterization of Spiropyran Initiated Hyperbranched Polyglycerol. 
SP was initially prepared according to a method described in the literature (Figure 1a).29 The prepared 
SP exhibited a clear color transition from colorless to pink upon excitation with UV light at 365 nm, 
displaying the desired UV-responsive character. The amphiphilic polymer SP-hb-PG was synthesized 
via anionic ring-opening polymerization using the SP initiator generated by treatment with cesium 
alkoxide, followed by the slow addition of a glycidol monomer (Figure 1b). Three different 
hyperbranched SP-hb-PG polymers varying in terms of the molecular weight of the hb-PG segment, 
which ranged from 1500 to 3000, were successfully prepared (Table 1). Initially, the molecular weight 
was determined from 1H NMR by integrating the signals of the aromatic groups of the SP initiator at 
8.3 ppm and those of the polyether backbone of hb-PGs in the range of 3.3 – 4.0 ppm (Figure 2a). These 
values were consistent with the theoretical target molecular weights as shown in Table 1. In addition, 
the Mn and the polydispersity index (Mw/Mn) of the prepared SP-hb-PGn samples were determined via 
GPC-RI, which showed a relatively monomodal molecular weight distribution with reasonable PDI 
values for all hyperbranched polymers. Notably, the discrepancy between the Mn values from GPC and 
NMR became slightly higher as the molecular weight of the polymer increased, which could be 
attributed to the use of a linear polystyrene standard in measuring the molecular weight of the hb-PG. 
Moreover, the hyperbranched nature of the SP-hb-PG was further confirmed by measuring the 
degree of branching (DB) via 13C NMR and calculation using Frey’s equation (DB = 2D / L13+L14+2D; 
L13:1,3 linear portion, L14:1,4 linear portion, and D: dendritic portion) (Figure 2b). This equation 
indicates the ratio of the branched dendritic segment within the PG backbones that are composed of 
both linear and branched segments. The DBs of all polymers were determined to be about 0.53, which 
is in good agreement with that of other hyperbranched systems.17  
The presence of each segment of SP and polyglycerol was also identified from the MALDI-ToF 
spectrum (Figure 3). As shown in Figure 3, the main molecular weight distribution at 1077.72 
corresponds to the molecular weight of SP-hb-PG with cesium as a counterion (SP(352) + PG(74.09) × 
8 + Cs+(133)) and the other molecular weight sub-distribution at 1093.90 corresponds to the molecular 
weight of SP-hb-PG with H+ as a counterion (SP(352) + PG(74.09) × 10 + H+(1)). In addition, the 
spacing between the main- and sub-distribution matches well with the molecular weight of the glycidol 
monomer, 74.09 g/mol, which indicates the successful polymerization of SP-hb-PG. 
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Figure 1. Synthetic Approach for Preparation of: a) Spiropyran Derivative Containing Hydroxyl Group, 
b) SP-hb-PG Polymers. 
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Table 1. Characterization of Spiropyran Initiated Hyperbranched Polyglycerol 
 
a Mn determined via 1H NMR spectroscopy. b Mn and Mw measured using GPC-RI in NMP with 
polystyrene standard. c Degree of branching (DB) is determined from inverse gated 13C NMR 
spectroscopy and calculated according to Frey’s equation (DB = 2D/2D+L) (see Supporting 
Information for details).  
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Figure 2. (a) 1H NMR and (b) Inverse gated 13C NMR spectrum of SP-hb-PG29 in DMSO-d6. 
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Figure 3. MALDI-ToF spectrum of SP-hb-PG15 (Entry 1 of Table 1), confirming each segment of SP-
hb-PG. 
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3.2. Micelle Formulation and Reversible Micelle System. 
As explained in the Experimental, the micelles were prepared from the amphiphilic SP-hb-PG29 
polymers by initial dissolution in DMF followed by the slow addition of excess amounts of DI water 
with subsequent dialysis. After preparation of the micelles, their morphology was investigated using 
transmission electron microscopy (TEM) and atomic force microscopy (AFM) (Figure 4). Based on the 
TEM and AFM images, the micelles possessed a spherical structure with a relatively narrow size 
distribution. The diameter of the micelles based on each measurement was similar, with values of 31.3 
± 8.1 nm (TEM) and 38.2 ± 9.4 nm (AFM), respectively.  
The UV-responsive nature of the SP-hb-PG polymers was evaluated by means of UV/Vis 
spectroscopy, where isomerization of the SP segment was induced by irradiation. Under irradiation with 
UV light (365 nm) for 30 min, a new absorption band appeared at 550 nm, corresponding to the 
absorption of MC, which reflects the isomerization of SP to generate the MC form (see Supporting 
Information, Figure 5). The solution color also changed from colorless to light pink upon UV 
irradiation. In contrast, the new peak disappeared under illumination with visible light (620 nm), which 
suggests the isomerization of MC to the SP form in the SP-hb-PG polymer. Interestingly, we found that 
this reversible isomerization could be repeated several times without any changes in the spectrum of 
SP-hb-PG (see Supporting Information, Figure 5).  
As a result of structural isomerization of neutral SP to zwitterionic MC, the amphiphilic SP-hb-PG 
is converted to the all-hydrophilic MC-hb-PG, which eventually drives the disassembly of the polymeric 
micelles as illustrated in Scheme 1. This reversible micelle assembly and disassembly was monitored 
by using dynamic light scattering (DLS) (Figure 6). The average diameter of the SP-hb-PG micelles 
measured by DLS was 33.2 ± 11.8 nm, which is similar to that determined from TEM and AFM 
measurement (Figure 4). Interestingly, the average diameter of the SP-hb-PG polymer decreased 
significantly to ca. 0.1 nm upon irradiation with UV light at 365 nm for 30 min, suggesting complete 
disassembly of the micelles into individual polymeric chains. This solution was again treated with 
visible light at 620 nm, at which point the average diameter returned to ca. 30 nm, similar to that of the 
initial micelles. The reversible nature of the micelle systems was confirmed from repeated DLS 
measurements. Light responsive deconstruction of micelle structures is important because after the 
delivery of a drug to a site using the micelles of SP-hb-PG, the structures can potentially disassemble 
into all-hydrophilic polymers of MC-hb-PG, which can be readily cleared and/or biodegraded. 
Furthermore, we evaluated the potential of the SP-hb-PG polymer micelles in carrying a model 
hydrophobic therapeutic, pyrene. First, to estimate the amphiphilicity of SP-hb-PG, the critical micelle 
concentrations (CMCs) of all SP-hb-PG polymers were determined via an established CMC 
measurement method using pyrene.30-31 A higher concentration of polymer solution induced greater  
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Figure 4. (a) TEM and (b) height-mode AFM images of SP-hb-PG29 micelles. (c, d) Corresponding 
size distributions determined by TEM and AFM showing an average diameter of 31.3 nm and 38.2 nm, 
respectively. Inset in (a) shows spherical morphology of micelles. 
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Figure 5. (a) UV/Vis spectrum of SP-hb-PG29 polymer upon UV light irradiation in MeOH 
solution. Left inset shows the color change of polymeric solution. Right inset shows the 
absorbance changes at 550 nm. (b) Cycle of absorbance at 550 nm wavelength under 
exposure of UV and Visible light. 
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Figure 6. Size distribution of polymeric micelle (under irradiation with 620 nm visible light, purple 
column) and polymer chain (under 365 nm UV light, blue column) of SP-hb-PG29 determined by DLS. 
Inset graph shows the diameter of SP-hb-PG29 polymeric micelles and polymeric chain under repetitive 
irradiation cycles using UV and visible light. 
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encapsulation of pyrene, which resulted in a red-shift of the excitation band at 334 nm and an increase 
in the intensity of the excitation band (see Supporting Information, Figure 7). To measure the shift of 
the excitation band, the ratio of the fluorescence intensity at 339 and 332 nm (I339/I332) was plotted as a 
function of the concentration of SP-hb-PG, in which a clear crossover point was observed in the low 
concentration range of 10 to 20 mg/L, corresponding to the CMC value. As summarized in Table 1, the 
CMC values of all of the polymers show that increasing the mass of the hydrophilic segment of SP-hb-
PG from 1500 to 3000 effectively increased the CMC values from 13 to 20 mg/L (Table 1). This 
observation can be attributed to the decreased hydrophobicity that efficiently reduced the segregation 
of the polymer blocks to accommodate the model hydrophobic therapeutics. This result is also 
consistent with our previous report.26 Because a longer glycerol segment reduces the amphiphilicity of 
the SP-hb-PG polymer, it is reasonable that the micelle formation of the amphiphilic polymer is 
generated at a higher concentration. 
Independent of the DLS measurement, the reversible nature of the micelle assembly and disassembly 
with pyrene can be characterized. As shown in Figure 8, the intensity of the fluorescence excitation 
band decreases depending on the UV irradiation time; this change is saturated after ca. 20 min with a 
slight blue-shift, indicating the release of pyrene from the micelle core. Interestingly, the plot of I339/I332 
with respect to the UV irradiation time shows a trend similar to the CMC experiment, which suggests 
degradation of the micelles. Moreover, the intensity of the fluorescence excitation spectra increases 
upon visible light irradiation. This observation is attributed to the re-encapsulation of released pyrene 
back into the micelle core, leading to the enhanced fluorescence band of the incorporated pyrene. 
However, this increase of the excitation intensity is terminated at 120 min and the recovered intensity 
is only about 40% of the initial intensity. This result implies that some portion of the released pyrene is 
not completely re-loaded into the SP-hb-PG micelle core (Figure 8a). It should be noted that 254-nm 
UV irradiation was employed in this case because of the enhanced release kinetics of pyrene from the 
micelle core compared to 365-nm irradiation (Figure 9). On the other hand, it should be also considered 
that the irradiation at 254-nm may induce the cell toxicity during the micelle disassembly (ca. 88.2% 
cell viability for HeLa cells after 30 min irradiation). We found that the cell viability varied depending 
on the wavelength and duration of the UV irradiation as similarly observed in other report (Figure 10).32 
Therefore, the current UV irradiation approach needs a better control to enhance the kinetics of 
demicellization while minimizing the cell toxicity induced by the irradiation, which will be the subject 
of our on-ongoing research. 
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Figure 7. (a) Excitation spectra of pyrene in SP-hb-PG29 micelles at concentration from 0 to 
116.62 mg/L in water and (b) CMC determination of I339 / I332 as a function of log c using 
pyrene fluorescence excitation spectra (emission wavelength of 372 nm). 
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Figure 8. (a) Illustration of pyrene release upon 254 nm UV-irradiation and re-encapsulation upon 620 
nm visible irradiation of SP-hb-PG micelles. (b) Changes in excitation spectrum of pyrene encapsulated 
by SP-hb-PG29 micelle under 254-nm UV irradiation and (c) 620-nm visible irradiation. Inset shows 
the plot of I339/I332 versus the exposure time to UV and visible light, respectively. 
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Figure 9. (a) Changes in excitation spectrum of pyrene encapsulated by SP-hb-PG29 micelle 
under 365-nm UV irradiation. (b) Plot of I339/I332 versus the exposure time to UV light. 
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Figure 10. MTT-based cell viability assay upon UV irradiation of 254 and 365 nm for 
different time (30 min, 1 h, and 2 h). (left) HeLa cell and (right) WI-38 cell. The cell viability 
was normalized to that without UV irradiation. 
 
 
  
72 
 
3.3. Biocompatibility Assay 
Finally, we evaluated the cytotoxicity of SP-hb-PGs to investigate their potential as a drug delivery 
carrier. The in vitro cytotoxicity of SP-hb-PGs was assessed by MTT assay using WI-38 cells and HeLa 
cells as respective model of normal cells and cancer cells (Figure 11). As a representative example, the 
viability of both cells after treating the SP-hb-PG36 micelle solution with varying concentrations was 
nearly 100%, even at a high concentration of 1000 µg/mL. These results indicate that the SP-hb-PGs 
are highly biocompatible and non-toxic to both cell lines. We cannot exclude the fact that the uptake 
efficiency of the SP-hb-PG micelles is relatively low; however, our previous report of doxorubicin-
conjugated polyglycerol micelles are readily internalized into the HeLa cells as proved by the confocal 
fluorescence microscopy.25 In other studies, a good cellular uptake of rhodamine-labeled hyperbranched 
PGs toward various types of cancer cell lines was demonstrated.33,34 Taken together these evidences in 
the literatures, we postulate that the similarly structured SP-hb-PG would undergo similar process to be 
internalized into the HeLa cells without exhibiting significant cytotoxicity. 
In addition, comparison of the toxicity of SP-hb-PGs toward normal WI-38 cells shows that an 
increase of the glycerol fraction is accompanied by slightly lowered cytotoxicity (Figure 11b). It is 
reasonable that SP-hb-PG of higher molecular weight exhibits greater biocompatibility due to the 
presence of a large fraction of highly biocompatible PG. 
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Figure 11. (a) Plot of cell viability of SP-hb-PG36 micelles determined by MTT assay, (b) WI-38 
(normal cell) viability of all SP-hb-PGn polymers. 
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4. Conclusion 
A novel light-responsive micelle system was developed using SP-hb-PG. Because of its considerable 
amphiphilicity, SP-hb-PG formed self-assembled polymeric micelles in aqueous medium. However, 
upon exposure to UV irradiation, the initially hydrophobic SP isomerized to zwitterionic MC, leading 
to the disassembly of the micelle structures. This structural change of the micelles was reversible upon 
exposure to visible light irradiation. The potential of the SP-hb-PG micelle for use as a smart drug 
delivery system was investigated using pyrene as a model hydrophobic therapeutic. The study suggested 
successful loading and release of pyrene upon external UV irradiation. In addition, the in vitro 
cytotoxicity of the SP-hb-PG polymers was evaluated using WI-38 and HeLa cells, demonstrating the 
excellent biocompatibility and non-toxicity of the SP-hb-PG micelles. We anticipate that this light-
responsive smart drug delivery system will provide a new means to sophisticated delivery of active 
therapeutics in a time-specific and stimuli-specific manner. 
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